This Article Full Text Full Text (PDF) All Versions of this Article: 53/2/243    most recent HYPERTENSIONAHA.108.118349v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Huang, W. Articles by Wang, D. H. Search for Related Content PubMed PubMed Citation Articles by Huang, W. Articles by Wang, D. H. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Medline Plus Health Information Heart Attack Related Collections Contractile function Other heart failure Acute myocardial infarction

(Hypertension. 2009;53:243.)
© 2009 American Heart Association, Inc.

Original Articles

Transient Receptor Potential Vanilloid Gene Deletion Exacerbates Inflammation and Atypical Cardiac Remodeling After Myocardial Infarction

Wei Huang; Jack Rubinstein; Alejandro R. Prieto; Loc Vinh Thang; Donna H. Wang

From the Department of Medicine (W.H., J.R., A.R.P., L.V.T., D.H.W.), Neuroscience Program (D.H.W.), and Cell and Molecular Biology Program (D.H.W.), Michigan State University, East Lansing; and the Department of Cardiology (W.H.), Chongqing Medical University, Chongqing, China.

Correspondence to Donna H. Wang, MD, FAHA, Division of Nanomedical and Molecular Intervention, Department of Medicine, B316 Clinical Center, Michigan State University, East Lansing, MI 48824. E-mail donna.wang{at}ht.msu.edu

The transient receptor potential vanilloid (TRPV1) channels expressed in sensory afferent fibers innervating the heart may be activated by protons or endovanilloids released during myocardial ischemia (MI), leading to angina. Although our previous in vitro data indicate that TRPV1 activation may preserve cardiac function after ischemia-reperfusion injury, the underlying mechanisms are largely unknown. To test the hypothesis that TRPV1 modulates inflammatory and early remodeling processes to prevent cardiac functional deterioration after myocardial infarction, TRPV1-null mutant (TRPV1^–/–) and wild-type (WT) mice were subjected to left anterior descending coronary ligation or sham operation. The infarct size was greater in TRPV1^–/– than in WT mice (P<0.001) 3 days after MI, and the mortality rate was higher in TRPV1^–/– than in WT mice (P<0.05) 7 days after MI. The levels of plasma cardiac troponin I; cytokines, including tumor necrosis factor-, interleukin-1β, and interleukin-6; chemokines, including monocyte chemoattractant protein-1 and macrophage inflammatory protein-2; and infiltration of inflammatory cells, including neutrophils, macrophages, and myofibroblasts; as well as collagen contents, were greater in TRPV1^–/– than in WT mice (P<0.05) in the infarct area on days 3 and 7 after MI. Changes in left ventricular geometry led to increased end-systolic and -diastolic diameters and reduced contractile function in TRPV1^–/– compared with WT mice. These data show that TRPV1 gene deletion results in excessive inflammation, disproportional left ventricular remodeling, and deteriorated cardiac function after MI, indicating that TRPV1 may prevent infarct expansion and cardiac injury by inhibiting inflammation and abnormal tissue remodeling.

Key Words: transient receptor potential vanilloid subtype • myocardial infarction • inflammation early remodeling • transgenic animal model